---
figid: PMC5501721__nihms869289f1
figtitle: Extracellular nutrients are required to maintain oncogenic signaling in
  brain cancer – a critical role for mTORC2
organisms:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC5501721
filename: nihms869289f1.jpg
figlink: /pmc/articles/PMC5501721/figure/F1/
number: F1
caption: mTORC2 signaling is elevated in many cancers via two distinct mechanisms.In
  non-small cell lung cancer and melanoma, Rictor amplification drives mTORC2 signaling
  while mTORC2 signaling is hyper-activated by upstream growth factor signaling pathway
  mutations in prostate cancer, leukemia and GBM. Hyper-activated mTORC2 can drive
  tumor formation, remodel an epigenome and transcription factor network, and facilitate
  metabolic reprogramming through an oncogenic transcription factor c-Myc. del, deletion;
  EGFRvIII, epidermal growth factor receptor variant III; GBM, glioblastoma multiforme;
  mut, mutation; NSCLC, non-small cell lung cancer; PI3K, phosphoinositide 3-kinase;
  PIK3CA, phosphatidylinositol (4,5)-bisphosphate 3-kinase catalytic subunit alpha;
  PIP2, phosphatidylinositol (4,5)-bisphosphate; PIP3, phosphatidylinositol (3,4,5)-trisphosphate;
  PTEN, phosphatase and tensin homolog deleted on chromosome 10; TF, transcriptional
  factor.
papertitle: Extracellular nutrients are required to maintain oncogenic signaling in
  brain cancer – a critical role for mTORC2.
reftext: Kenta Masui, et al. Bioessays. ;38(9):839-844.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9574115
figid_alias: PMC5501721__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC5501721__F1
ndex: 2b507e5a-dedf-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5501721__nihms869289f1.html
  '@type': Dataset
  description: mTORC2 signaling is elevated in many cancers via two distinct mechanisms.In
    non-small cell lung cancer and melanoma, Rictor amplification drives mTORC2 signaling
    while mTORC2 signaling is hyper-activated by upstream growth factor signaling
    pathway mutations in prostate cancer, leukemia and GBM. Hyper-activated mTORC2
    can drive tumor formation, remodel an epigenome and transcription factor network,
    and facilitate metabolic reprogramming through an oncogenic transcription factor
    c-Myc. del, deletion; EGFRvIII, epidermal growth factor receptor variant III;
    GBM, glioblastoma multiforme; mut, mutation; NSCLC, non-small cell lung cancer;
    PI3K, phosphoinositide 3-kinase; PIK3CA, phosphatidylinositol (4,5)-bisphosphate
    3-kinase catalytic subunit alpha; PIP2, phosphatidylinositol (4,5)-bisphosphate;
    PIP3, phosphatidylinositol (3,4,5)-trisphosphate; PTEN, phosphatase and tensin
    homolog deleted on chromosome 10; TF, transcriptional factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
  - del
  - tx
  - mirr
  - fs(1)de1
  - rictor
  - Mtor
  - Tor
  - tf
  - Myc
  - MMUT
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - TF
  - MYC
  - Mmut
  - Pik3ca
  - Pik3r1
  - Rictor
  - Nol3
---
